Through analysis of the molecular markers by immunohistochemistry, breast cancer is classified into four types based on different expressions of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER-2), and Ki67 index [19–21]. This evidence concerns the gene ERBB2 and breast carcinoma.